Difference in Serum Estrogen Level Based on Methods of Vaginal Estrogen Application (fingertip Vs Applicator Use) in Post-menopausal Women
NCT06808347 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 110
Last updated 2025-02-05
Summary
Study the change in serum estrogen level based on the method of vaginal cream application (applicator vs fingertip application) and Measure patient satisfaction with vaginal estrogen cream application based on the method of application using a validated patient questionnaire (Likert scale).
Conditions
- Postmenopausal Atrophic Vaginitis
- Genitourinary Syndrome of Menopause
Interventions
- DRUG
-
application of the vaginal estrogen cream
patients will apply the vaginal estrogen cream
Sponsors & Collaborators
-
Walter Reed National Military Medical Center
lead FED
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-02-01
- Primary Completion
- 2025-06-30
- Completion
- 2025-09-30
More Related Trials
-
Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women
NCT01816139 ·Status: COMPLETED ·Phase: PHASE3
-
Vaginal and Urinary Microbiome Trial
NCT02869165 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of a Topical Estradiol Gel for Treatment of Postmenopausal Symptoms
NCT00391417 ·Status: COMPLETED ·Phase: PHASE3
-
Treating Postmenopausal Dyspareunia Where it Hurts
NCT03240081 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal Atrophy
NCT00361569 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic Vaginitis
NCT00465192 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial to Evaluate the Efficacy of Low Dose Vaginal Estrogens in the Treatment of Atrophic Vaginitis
NCT00816556 ·Status: TERMINATED ·Phase: PHASE3
-
A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy
NCT02670785 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis
NCT01486979 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Vaginal Estrogen on Serum Estradiol During Aromatase Inhibitor Therapy in Breast Cancer Patients with Vulvovaginal Atrophy: a Prospective Trial
NCT06654570 ·Status: COMPLETED ·Phase: PHASE2
-
Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency
NCT01507454 ·Status: COMPLETED
-
Sexual Effects of Transdermal or Vaginal Testosterone
NCT06794346 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Comparison of Two Vaginal Tablets, Produced at Different Sites, in Postmenopausal Women With Atrophic Vaginitis
NCT01085877 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women
NCT02224313 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing Estradiol Vaginal Cream to Estrace® Cream in Females With Atrophic Vaginitis
NCT02995694 ·Status: COMPLETED ·Phase: PHASE3
-
The Vaginal Health Trial
NCT02516202 ·Status: COMPLETED ·Phase: PHASE3
-
Hormone Replacement Therapy for Use in Postmenopausal Women for Relief of Hot Flushes and Urogenital Symptoms.
NCT01070979 ·Status: COMPLETED ·Phase: PHASE3
-
Silicone Gel vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of Menopause
NCT05672901 ·Status: RECRUITING ·Phase: NA
-
Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women
NCT02253173 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety and Bioequivalence of Estradiol Vaginal Inserts, 10 mcg and Vagifem® 10 mcg and Compare to Placebo
NCT01779947 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy
NCT00160173 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy of Topical Vaginal Oxytocin Gel in Postmenopausal Women With Vulvovaginal Atrophy
NCT06514586 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Estrogen and Platelet Rich Plasma in Treatment of Atrophic Vaginitis
NCT05118685 ·Status: UNKNOWN ·Phase: PHASE1
-
Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia
NCT01845649 ·Status: COMPLETED ·Phase: PHASE3
-
Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.
NCT01122342 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2